Literature DB >> 10764335

Analysis of HLA antigens in Mycobacterium avium-intracellulare pulmonary infection.

K Kubo1, Y Yamazaki, M Hanaoka, H Nomura, K Fujimoto, T Honda, M Ota, Y Kamijou.   

Abstract

Mycobacterium avium-intracellulare (MAI) pulmonary infection may occur in subjects with no preexisting lung disease and no known immunodeficiency, showing radiologically nodular bronchiectasis. There have remained some unresolved problems in the pathogenesis of the disorder, including the predominance in elderly women and the presence of not deteriorated or deteriorated disease. In the present study, we examined whether immunogenetic susceptibility is present in the disorder. We evaluated 64 cases of MAI disease and analyzed their short-term natural history by assessing symptoms, sputum bacteriology, and chest computed tomographic findings. The frequencies of human leukocyte antigen (HLA) alleles in patients were compared with those in 100 healthy Japanese control subjects. We assayed the HLA-A, -B, -C, -DR, and -DQ antigens serologically. Among 64 patients, 37 (35 females) did not show deterioration, whereas 27 (24 females) showed deterioration after an interval of 30 +/- 15 mo. There was no significant frequency of HLA-B and -C alleles in either group. In 37 not deteriorated patients, DR-6 was positive in 14 (37.8%) patients but in only 16 (16%) control subjects (p = 0.0061, odds ratio [OR] = 3.20). DQ-4 was positive in 10 (27.0%) patients but in only 10 (10%) control subjects (p = 0. 0122, OR = 3.33). In 27 deteriorated patients, HLA-A26 was positive in 14 (51.9%) patients but in only 21 (21.0%) control subjects (p = 0.0015, OR = 4.05). MAI pulmonary infection with nodular bronchiectasis shows two types of outcome, deteriorated and not deteriorated. The subjects with A-26 antigen might indicate the deterioration of MAI infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764335     DOI: 10.1164/ajrccm.161.4.9906094

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  8 in total

1.  Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease.

Authors:  M Ashworth Dirac; Kathleen L Horan; David R Doody; J Scott Meschke; David R Park; Lisa A Jackson; Noel S Weiss; Kevin L Winthrop; Gerard A Cangelosi
Journal:  Am J Respir Crit Care Med       Date:  2012-08-02       Impact factor: 21.405

Review 2.  Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.

Authors:  D Rebecca Prevots; Theodore K Marras
Journal:  Clin Chest Med       Date:  2014-11-06       Impact factor: 2.878

3.  HLA antigens and nontuberculous mycobacterial lung disease in Korean patients.

Authors:  Sang-Won Um; Chang-Seok Ki; O Jung Kwon; Won-Jung Koh
Journal:  Lung       Date:  2009-02-14       Impact factor: 2.584

Review 4.  Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective.

Authors:  Won-Jung Koh; O Jung Kwon; Kyung Soo Lee
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

5.  Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity.

Authors:  R J Boyton; J Smith; M Jones; C Reynolds; L Ozerovitch; A Chaudhry; R Wilson; M Rose; D M Altmann
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

Review 6.  Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis.

Authors:  Giulia Bonaiti; Alberto Pesci; Almerico Marruchella; Giuseppe Lapadula; Andrea Gori; Stefano Aliberti
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

Review 7.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

8.  A case of familial hot tub lung.

Authors:  Yoshihiro Kitahara; Yusuke Araki; Kikuo Nakano
Journal:  Respir Med Case Rep       Date:  2016-02-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.